Nefeli Chanoutsi is the Chief Operating Officer at ALegacy L.L.C.. She brings expertise in research, business, and operations to the team. Having earned her Master of Science in Molecular Biomedicine from Heinrich-Heine University in Germany, Nefeli has engaged in cutting-edge biomedical research at renowned institutions like UC Berkeley and UC San Francisco’s Quantitative Biosciences Institute. 

With her extensive background in research and operations, Nefeli Chanoutsi brings a wealth of expertise to her role as Chief Operating Officer at ALegacy L.L.C. Her leadership in establishing protocols, improving processes, and managing daily operations aligns perfectly with the company's mission to foster growth and innovation through strategic investments and sustainable development projects.

Nefeli was named a PROMOS Scholar, by the German Academic Exchange Service, DAAD for short, and won awards such as a gold medal in the International Genetically Engineered Machines (iGEM) competition. Nefeli’s work underscores her exceptional intellectual merit and vision. She has led several research projects at the Quantitative Biosciences Institute, University of California in San Francisco (UCSF), where she established protocols, improved processes, and oversaw daily operations. Her leadership and innovative approach drive ALegacy L.L.C. towards new scientific and technological frontiers.

In her free time she enjoys exploring new activities, playing board games, practicing martial arts, and dancing with friends.